The White House has quietly updated its biodefense strategy, and the first line of the memo reads like a sci-fi thriller: “AI is supercharging biological threats.” I read it while watching evening light filter through the old jacaranda tree outside my window in Nairobi, and I felt a familiar unease—the same kind I felt in 2017 when I audited a smart contract that had a silent fallback function designed to drain liquidity. The code looked clean on the surface, but the hidden edges were sharp. This new policy is a similar kind of code: a centralized response to a decentralized problem. And as someone who has spent years building open-source education platforms in the crypto space, I see the same pattern of control being woven into the architecture of our future.
Tracing the moral code behind every token.
The context here is not merely about public health. The White House’s action is a direct acknowledgment that the convergence of artificial intelligence and synthetic biology has crossed a threshold. We are no longer in a world where biological weapons are the domain of state actors with billion-dollar labs. AI-powered protein design, automated gene synthesis, and accessible CRISPR tools mean that a small group with malicious intent could engineer a pathogen that is both novel and highly transmissible. The 2022 National Biodefense Strategy laid the groundwork, but this new push—rumored to include mandatory screening of all DNA synthesis orders and a centralized AI threat intelligence hub—signals a shift from preparedness to active preemption.
From my perspective as a blockchain architect, what is missing is not intention but transparency. The current framework is a classic top-down model: a few agencies in Washington will hold the keys to a massive database of genomic sequences, research activity, and threat assessments. That is a centralized oracle, and as I have learned from auditing DeFi protocols, centralized oracles are the single point of failure. They can be hacked, politically captured, or simply corrupted by the very human tendency to hoard power. I think of the 2020 DeFi summer, when projects like Harvest Finance lost millions because of oracle manipulation. The biodefense of a nation cannot afford such a flaw.
Here is the core technical insight: blockchain can serve as the immutable ledger for biosecurity, but only if we design it with the right ethical primitives.
Consider the problem of synthetic DNA screening. The White House’s proposed framework asks gene synthesis companies to check orders against a list of dangerous sequences. But who maintains that list? Who decides what is dangerous? In a centralized system, the list becomes a political tool—a way to ban research on certain pathogens, or to discriminate against labs in adversary nations. On a public blockchain, we could create a decentralized registry of known hazardous sequences, updated by a global network of research institutions, each running a node. A smart contract could automatically reject any gene order that matches a flagged sequence, but the governance of that registry would be transparent and auditable by all participants. This is not a pipe dream; similar mechanisms already exist in supply chain tracking for pharmaceuticals. We simply need to extend the logic to the raw material of life itself.
But there is a deeper layer. The real threat that the White House memo does not discuss is the loss of provenance in biological research. When a paper publishes a new AI-designed protein, how do we know that the same software was not used to design a toxin? How do we trace the lineage of a sequence from the lab bench to the public database? In the NFT world, we obsess over provenance for digital art—why not for the building blocks of our biology? A blockchain-based system could assign a unique, non-fungible token to every synthetic DNA sequence, recording its origin, the AI model used to create it, and the lab where it was synthesized. This would make it far harder for bad actors to hide their work, and far easier for regulators to track the flow of dangerous materials. I have seen this work in practice: during the Savanna Voices NFT project, we used a DAO to track the provenance of each piece of digital art, ensuring that artists received royalties even after secondary sales. The same principle can be applied to DNA sequences, with the royalties going not to artists but to the custodians of the genetic commons.
Building libraries where others build empires.
Yet I must pause and offer a contrarian view. The very idea of a “global unified governance” for biosecurity, as the White House advocates, may be a Trojan horse for a new kind of digital empire. The same agencies that want to centralize threat data are also the ones that control the internet’s backbone. They are the ones who have, in the past, demanded backdoors in encryption. In the crypto world, we have learned that “code is law” is a myth when a few multi-sig signers can change the rules at any time. The proposed biodefense system, if built on a centralized database, will be subject to the same vulnerabilities. The real risk is not that AI will enable a bioweapon in the hands of a terrorist—it is that the response to that fear will create a surveillance infrastructure that suffokes scientific freedom and further entrenches the power of a few states.
I recall a conversation with a young developer from my Open Ledger project in Nairobi. She asked me, “Why do we need permission to study a protein? Who owns the data of my own genome?” She was echoing the same unease I feel. The White House’s strategy is defensive, but it is also a power grab. The United States wants to lead the global standard for biosecurity, and that standard will be defined by American interests. The rest of the world will be forced to comply. This is the opposite of the decentralized, permissionless future that blockchain promises. It is a new form of imperialism, written in the language of safety.
Preserving the human story in digital ledgers.
The contrarian reality is that the AI-bio threat is being used as a justification for a new kind of industrial-military complex. The biodefense industry will boom, and the big players—pharma giants, defense contractors, AI startups—will be the ones to profit. The communities that are most vulnerable to biological threats, such as those in the Global South, will be the last to receive the benefits. I have seen this pattern before: in the 2022 NFTs, the hype cycle favored collectors and speculators, not the artists. Here, the hype cycle of “AI-bio Armageddon” will favor the centralized gatekeepers, not the global commons.
So where does this leave us? The blockchain community has a unique opportunity to build a counter-narrative. We can create a decentralized biosecurity infrastructure that is open, transparent, and equitable. We can deploy smart contracts for gene synthesis screening that are governed by a global DAO, not by a single agency. We can use zero-knowledge proofs to allow researchers to prove they are not working on dangerous sequences without revealing their entire research agenda. We can build a public ledger of all AI-designed biological sequences, so that the provenance of life remains in the hands of the many, not the few.
But this will require that we move beyond the hype of crypto and into the hard work of ethical engineering. It will require that we listen to the silence between the blocks—the voices of the scientists in developing countries, the bioethicists who have been warning about gain-of-function research, and the artists who remind us that life is not a commodity. The White House has drawn a line in the sand. It is up to us to decide whether that line becomes a wall or a bridge.
Walking away from the hype to find the soul.
As I write this, I am thinking of the students in my DeFi library project. They are learning to code, but more importantly, they are learning to question authority. They ask me, “Who audits the auditor?” That is the question we must ask of the new biodefense strategy. Who audits the White House’s code? Who ensures that the list of dangerous sequences is not used to suppress legitimate research? Who guarantees that the data we share about our own genomes is not used against us? The answer, I believe, lies in the very technology that the crypto world has pioneered: the decentralized ledger. It is not a perfect solution, but it is the only one that aligns with the values of openness, transparency, and human dignity.
The White House sees a threat. I see an opportunity. But the opportunity will only be realized if we act with the same intensity that we bring to auditing a smart contract. We must trace the moral code behind every policy, every standard, every line of code. We must build libraries, not empires. And we must preserve the human story—not just in digital ledgers, but in the very fabric of how we choose to govern the most powerful tools of our age.